Insider trade

Director sold ~$467K of HIMS shares in the open market

Traded Aug 18, 2026 · Filed Aug 20, 2026

Why it stands out

A board member of Hims & Hers Health sold $467K of Hims & Hers Health shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$100K–$500KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$467,128

Shares × reported transaction price

Timing vs results

8 days after results of Aug 10, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−14.6%	+0.5%	−15.1%
30 days	−13.1%	+1.0%	−14.1%

Past results only. Not a forecast.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Scheduled in advance3w ago

Scheduled in advance3w ago

Scheduled in advance3w ago